Amgen 🧪🔬🧬

Amgen is investing an additional $300M in its U.S. manufacturing network to advance production capacity, enhance next-generation technologies and support a reliable supply of medicines. Total U.S. manufacturing investments announced over the past year now reach nearly $2B. 🔗See how Amgen is leading what’s next in biotech innovation: amgen.ly/4tPfB7l $AMGN

Headed to #ECO2026? Join us for our symposium and learn more about the evolving obesity treatment landscape. 🔗Learn more about our scientific approach to obesity: amgen.ly/4np5bZM

@Tim46023972 Hello, we've sent you a DM. Thank you.

@Tim46023972 Thank you for your message. We would like to contact you to learn more. Can you follow us back so we can send you a DM?

@Amgen My spouse developed horrible skin rash and hives after using Repatha. We are having to pay for your product side effects. Your autoinjector failed.

@CatLady_Anne Thank you for your message. We would like to contact you to learn more. Can you follow us back so we can send you a DM?

@Amgen Dangerous drug. Your teams are badly trained.

Amgen is investing an additional $300M in its U.S. manufacturing network to advance production capacity, enhance next-generation technologies and support a reliable supply of medicines. Total U.S. manufacturing investments announced over the past year now reach nearly $2B. 🔗See how Amgen is leading what’s next in biotech innovation: amgen.ly/4tPfB7l $AMGN

How do you navigate B-cell ALL at 21? After years of hospital stays & uncertainty, William is in remission. Now he’s helping other young people advocate for themselves. Read his story: amgen.ly/49pJfI3 @TheMightySite #AmgenSponsored

AMGEN continúa fortaleciendo su presencia en nuestra isla con una inversión adicional de $300 millones, impulsando la creación de empleos, el desarrollo económico y nuevas oportunidades para nuestra gente. Por más de tres décadas, esta alianza ha sido parte clave del crecimiento industrial y científico de Puerto Rico, demostrando la confianza de empresas globales en el talento puertorriqueño y en el potencial de nuestra isla.

Amgen reports Q1 2026 earnings: amgen.ly/4tcBhcv Safe Harbor: amgen.ly/4cYdXJc $AMGN

Amgen will report Q1 2026 financial results tomorrow. Details here: amgen.ly/4vQMMsC $AMGN

Amgen will report Q1 2026 financial results on Thursday, April 30. Details here: amgen.ly/4ee1JPb $AMGN

🔬Amgen San Francisco has expanded with new small-molecule discovery labs. Powered by the DMTA cycle: Design → Make → Test → Analyze Scientists are working to accelerate discovery, designing molecules that could one day become medicines. 🎉

We’re excited to share positive Phase 3 data evaluating a subcutaneous administration of our treatment for Thyroid Eye Disease (TED) in people with moderate-to-severe active TED. 🔗 Read the press release to learn more: amgen.ly/4tBdnrP $AMGN

@Tim46023972 We've just followed you. Can you follow us back so we can learn more. Thank you.

@Amgen Had a failure with a auto injector. I sent it back to you. Waiting on an answer.....

Amgen has published its 2025 Letter to Shareholders. 🔗amgen.ly/4v1q40t This year’s letter highlights our strong performance in 2025 and how we are advancing innovative medicines, driving scientific innovation, and investing in manufacturing to better serve patients around the world. $AMGN

📢 NEWS: Late-breaking Phase 3 data presented at @ACCinTouch’s #ACC26 support earlier intensive LDL-C lowering to reduce the risk of a first major CV event in high-risk patients without known atherosclerosis. ➡️ Read more: amgen.ly/4lSs2vO

At Amgen, AI’s role goes far beyond molecule discovery. In this sponsored WIRED feature, leaders share how it’s being used to support how medicines are discovered, developed and delivered. AI tools are on track to help Amgen reduce the duration of certain changeovers by as much as 36 percent. See what applied AI looks like at Amgen: amgen.ly/3NuINAN

Thank you @RepLuzRivas for joining @AmgenFoundation ABE students in the classroom.

@cardoni Hi Greg, thanks for reaching out to us. Sending you a DM now.

@AmericaPapaBear My old @Amgen buddies would’ve laughed at this. One in particular. Named Mike.

This is why the internet was made.

For many patients with atherosclerotic cardiovascular disease (#ASCVD), experiencing a cardiovascular event is the start of chronic disease management—with costs that extend well beyond the initial episode. When cardiologists and primary care physicians are positioned earlier in the care continuum, they can help reduce downstream burden for patients.

Amgen reports Q4 and FY 2025 earnings: amgen.ly/49WY5qj Safe Harbor: amgen.ly/4qXb4yf $AMGN